Smart insulin pump feature for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an artificial intelligence feature that helps the insulin pump deliver extra insulin before meals. It aims to improve blood sugar control for adults with type 1 diabetes who already use an automated insulin delivery system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have type 1 diabetes for at least one year.
- You must already be using an automated insulin delivery (AID) system (a pump that adjusts insulin automatically).
- You must be willing to switch to a study-approved insulin and use the study's AID system (which includes a continuous glucose monitor, insulin pump, and phone).
- You must have someone nearby who can help in an emergency and contact medical services if needed.
- You must be able to read and write in English and have internet access at home.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
Hear when a new Type 1 Diabetes Mellitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.